🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a multi-center, non-randomized, single-arm, open clinical tri...
Status
Unknown
Location
Hematology Department, Hebei Medical University Fourth Hospital
Start Date
2020-10-22
Trial ID
NCT04665063
Treatments Being Tested
Long-term follow-up of patients exposed to an AUTO CAR T cell therapy for u...
Status
Enrolling By Invitation
Location
University of Miami
Start Date
2018-08-02
Trial ID
NCT03628612
Treatments Being Tested
This study is a multi-center, non-randomized, single-arm, open clinical tri...
Status
Unknown
Location
Hematology Department, Hebei Medical University Fourth Hospital
Start Date
2020-10-22
Trial ID
NCT04665076
Treatments Being Tested
This single-arm, dose-escalation exploratory trial evaluates the safety and...
Status
Not Yet Recruiting
Location
The First Affiliated Hospital with Nanjing Medical University
Start Date
2025-08
Trial ID
NCT07113496
Treatments Being Tested
The purpose of this study is to test the safety of giving the patient speci...
Status
Active Not Recruiting
Location
Memorial Sloan Kettering Cancer Center
Start Date
2011-09
Trial ID
NCT01430390
Treatments Being Tested
Chimeric Antigen Receptor T-Cell (CAR-T) immunotherapy is a rapidly develop...
Status
Not Yet Recruiting
Location
The Affiliated Hospital of Xuzhou Medical University
Start Date
2025-07-01
Trial ID
NCT07034755
Treatments Being Tested
This is a prospective study comparing anti-BCMA CAR-T to autologous hematop...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-07-15
Trial ID
NCT07070934
This is an open, single-arm, prospective，clinical study to evaluate efficac...
Status
Unknown
Location
Pediatric hematology, Hebei Medical University Fourth Hospital
Start Date
2020-06-23
Trial ID
NCT04610125
Treatments Being Tested
A Phase 1 dose-escalation study designed to evaluate the safety, tolerabili...
Status
Recruiting
Location
UCLA Medical Center
Start Date
2025-04-30
Trial ID
NCT06626919
Treatments Being Tested
The clinical study of CART19 Cells treatment for MRD of B Cell Malignancies...
Status
Unknown
Location
Weihong Chen
Start Date
2018-06-01
Trial ID
NCT03685786
Treatments Being Tested